AGEN
Price
$4.13
Change
+$0.70 (+20.41%)
Updated
Jun 2 closing price
Capitalization
113.23M
NRXP
Price
$2.70
Change
+$0.02 (+0.75%)
Updated
Jun 3, 10:30 AM (EDT)
Capitalization
46.34M
Interact to see
Advertisement

AGEN vs NRXP

Header iconAGEN vs NRXP Comparison
Open Charts AGEN vs NRXPBanner chart's image
Agenus
Price$4.13
Change+$0.70 (+20.41%)
Volume$1.68M
Capitalization113.23M
NRX Pharmaceuticals
Price$2.70
Change+$0.02 (+0.75%)
Volume$3.7K
Capitalization46.34M
AGEN vs NRXP Comparison Chart
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. NRXP commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and NRXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (AGEN: $4.13 vs. NRXP: $2.68)
Brand notoriety: AGEN and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 219% vs. NRXP: 51%
Market capitalization -- AGEN: $113.23M vs. NRXP: $46.34M
AGEN [@Biotechnology] is valued at $113.23M. NRXP’s [@Biotechnology] market capitalization is $46.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXP is a better buy in the long-term than AGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while NRXP’s TA Score has 5 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • NRXP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +8.12% price change this week, while NRXP (@Biotechnology) price change was +2.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.48%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +2.04%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 17, 2025.

NRXP is expected to report earnings on Mar 14, 2025.

Industries' Descriptions

@Biotechnology (+8.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($113M) has a higher market cap than NRXP($46.3M). NRXP has higher P/E ratio than AGEN: NRXP (0.36) vs AGEN (0.14). AGEN YTD gains are higher at: 50.730 vs. NRXP (21.818). NRXP has higher annual earnings (EBITDA): -24.89M vs. AGEN (-77.64M). AGEN has more cash in the bank: 44.8M vs. NRXP (1.44M). NRXP has less debt than AGEN: NRXP (6.58M) vs AGEN (78.4M). AGEN has higher revenues than NRXP: AGEN (160M) vs NRXP (0).
AGENNRXPAGEN / NRXP
Capitalization113M46.3M244%
EBITDA-77.64M-24.89M312%
Gain YTD50.73021.818233%
P/E Ratio0.140.3639%
Revenue160M0-
Total Cash44.8M1.44M3,105%
Total Debt78.4M6.58M1,192%
FUNDAMENTALS RATINGS
AGEN vs NRXP: Fundamental Ratings
AGEN
NRXP
OUTLOOK RATING
1..100
2017
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5138
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NRXP's Valuation (58) in the null industry is somewhat better than the same rating for AGEN (96) in the Biotechnology industry. This means that NRXP’s stock grew somewhat faster than AGEN’s over the last 12 months.

NRXP's Profit vs Risk Rating (100) in the null industry is in the same range as AGEN (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to AGEN’s over the last 12 months.

NRXP's SMR Rating (100) in the null industry is in the same range as AGEN (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to AGEN’s over the last 12 months.

NRXP's Price Growth Rating (38) in the null industry is in the same range as AGEN (51) in the Biotechnology industry. This means that NRXP’s stock grew similarly to AGEN’s over the last 12 months.

NRXP's P/E Growth Rating (100) in the null industry is in the same range as AGEN (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to AGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENNRXP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANIP61.913.19
+5.43%
ANI Pharmaceuticals
TX28.831.45
+5.30%
Ternium SA
CSX31.24-0.35
-1.11%
CSX Corp
UONEK0.69-0.01
-1.43%
Urban One
BETR12.74-0.70
-5.24%
Better Home & Finance Holding Company

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
+20.41%
SNPX - AGEN
91%
Closely correlated
+6.36%
ALLR - AGEN
87%
Closely correlated
+3.23%
NRXP - AGEN
83%
Closely correlated
+1.52%
PALI - AGEN
81%
Closely correlated
+2.43%
AXON - AGEN
42%
Loosely correlated
+1.09%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with RNAC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+1.52%
RNAC - NRXP
86%
Closely correlated
+4.39%
NCNA - NRXP
85%
Closely correlated
+7.65%
SNPX - NRXP
84%
Closely correlated
+6.36%
AGEN - NRXP
83%
Closely correlated
+20.41%
ALLR - NRXP
81%
Closely correlated
+3.23%
More